Gross Margin
-1.13%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 1.02%.Updated Aug 19, 2026Profit Margin
-8.80%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
-10.17%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
-5.29%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
-70.80%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
394.83MCNY58.64M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
3.12CNYUpdated Aug 19, 2026Quarterly Revenue Growth
3.70%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
4.04MCNY599.76K · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
-12.11MCNY-1.80M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
-34.75MCNY-5.16M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
-36.18%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
-19.03MCNY-2.83M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
-36.79MCNY-5.46M · vs all stocks (USD) Updated Aug 19, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 19, 2026Minority Interest (Equity)
11.08MCNYFY2025 · Dec 31, 2025Revenue
391.75MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
381.11MCNYFY2025 · Dec 31, 2025Gross Profit
10.64MCNYFY2025 · Dec 31, 2025Operating Income
-19.68MCNY-2.92M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-30.98MCNYFY2025 · Dec 31, 2025Net Income
-30.98MCNYFY2025 · Dec 31, 2025EBIT
-22.86MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-2.30MCNYFY2025 · Dec 31, 2025Research & Development
16.49MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
5.14MCNYFY2025 · Dec 31, 2025Other Operating Expenses
752.91KCNYFY2025 · Dec 31, 2025Non-operating Interest Income
41.51KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
8.12MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2159CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2159CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
126.70MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
126.70MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-30.98MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.62MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-44.58MCNYFY2025 · Dec 31, 2025Free Cash Flow
-64.45MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
7.19MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-30.98MCNYFY2025 · Dec 31, 2025Other Non-cash Items
8.12MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.36MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-16.37MCNYFY2025 · Dec 31, 2025Capital Expenditures
-19.86MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.75MCNYFY2025 · Dec 31, 2025Other Investing Activity
620.59KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-20.99MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
468.88MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-426.29MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-7.62MCNYFY2025 · Dec 31, 2025Other Financing Charges
763.76KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
35.74MCNYFY2025 · Dec 31, 2025